A method for the establishment of a pluripotent human blastocyst-derived stem cell line
CA 2471540 A1 · Owner: Cell Therapeutics Scandinavia Ab · Inventors: Semb, Henrik; Tonning, Anna
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns a method for the establishment of pluripotent human blastocyst-derived stem (BS) cell line stem cells obtained by the , method, differentiation of these cells into differentiated cells the , differentiated cells and the use of these differentiated cells in the preparation of medicaments. The undifferentiated pluripotent stem cells can be made to differentiate to a number of specialized cell types which can be utilized in the manufacture of medicaments for treating a number of conditions or pathologies involving degeneration of tissue e.g. of the pancreas leading to e.g. development of diabetes, or of the CNS (e.g. Alzheimer's Parkinson's , disease etc.) …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 27, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.